◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Sumitomo Pharma Co., Ltd. (4506) Financial History

Name: Sumitomo Pharma Co., Ltd. (4506) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Sumitomo Pharma Co., Ltd. (4506) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Osaka, Japan. Its market capitalization is roughly JPY 603 billion. In the fiscal year ended 2026-03-31, 4506 reported JPY 453.3B in revenue and JPY 106.9B in net income.

Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia.

Interactive charts & full statements →

4506 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Revenue	JPY 453.3B	JPY 398.8B	JPY 314.6B	JPY 555.5B	—
Gross Profit	JPY 256.9B	JPY 245.4B	JPY 188.0B	JPY 376.6B	—
Operating Income (EBIT)	JPY 105.1B	JPY 29.7B	(JPY 354.8B)	(JPY 77.0B)	—
Net Income	JPY 106.9B	JPY 23.6B	(JPY 315.0B)	(JPY 74.5B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4506 Free Cash Flow History

Cash flow	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 3M)	(JPY 2.8B)	(JPY 11.1B)	(JPY 11.1B)

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4506 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	JPY 804.6B	JPY 742.6B	JPY 907.5B	JPY 1.13T	—
Total Liabilities	JPY 512.1B	JPY 573.1B	JPY 751.4B	JPY 728.0B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4506 viewer.

4506 Metric Deep Dives

Other Companies in Drug Manufacturers - Specialty & Generic

4502 · Takeda Pharmaceutical Company Limited — $8.91 trillion
4507 · Shionogi & Co., Ltd. — $2.42 trillion
4523 · Eisai Co., Ltd. — $1.40 trillion
4151 · Kyowa Kirin Co., Ltd. — $1.34 trillion
1276 · Jiangsu Hengrui Pharmaceuticals Co.,Ltd — $382 billion
4540 · Tsumura & Co. — $280 billion
4516 · Nippon Shinyaku Co., Ltd. — $242 billion
3692 · Hansoh Pharmaceutical Group Company Limited — $200 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4503 All “0-9” companies 4507 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.